An FDA application for TAR-200 to treat BCG-unresponsive high-risk non-muscle-invasive bladder cancer is under real-time ...

Johnson & Johnson (JNJ) said it has submitted an application to the FDA for its therapy candidate TAR-200 for the treatment of a certain type of bladder cancer. Read more here.

The New Brunswick, N.J., pharmaceutical giant said the FDA accepted the application through its Real-Time Oncology Review program, which allows for an earlier submission of topline efficacy and safety ...

(RTTNews) - Johnson & Johnson (JNJ) Wednesday said it has initiated the submission of new drug application or NDA to Food and Drug Administration (FDA) for TAR-200 to treat patients with Bacillus ...

Johnson & Johnson announced it has initiated the submission of an original New Drug Application with the U.S. FDA for TAR-200 for the ...

The New Drug Application for TAR-200 is supported by results from the Phase IIb SunRISe-1 study, which demonstrated an 83.5% ...

The pharma began submitting its TAR-200 bladder cancer treatment to the FDA. Elsewhere, Sarepta and Madrigal reported strong ...

The Food and Drug Administration is banning the use of Red No. 3, an artificial dye linked to cancer in animals, from food and ingested drugs. Johnson & Johnson initiated an application seeking Food ...

Art Chansky previews a Wednesday night showdown between two of the ACC's top shooters: Cal's Andrej Stojakovic and UNC's Ian ...

Kodarma Chemical Private Limited, a company specializing in the extraction of aromatic hydrocarbons like benzene, toluene, ...

As a freshman, Latson led the ACC in scoring with 21.3 points per game. The guard has started every game since arriving in Tallahassee, barring injury, and this year’s 26.8 points per game is the top ...

Matt Norlander's insider notebook is stuffed this week, including Mick Cronin's Big Ten issues, reader questions and much ...